A strategy of live related donor kidney transplantation coupled to the briefest possible preparatory period of haemodialysis was adopted as the most cost effective treatment for a selected group of 9 Tanzanian patients who received a total of 10 grafts. Patient and donor selection and preparation were carried out at Muhimbuli Medical Centre, Dar es Salaam, and the transplant procedure and first few months of follow-up were done at St. Thomas' Hospital, London. There was a high incidence of complications which drew attention to particular risk factors in the group treated. The high cost of treating these individuals emphasizes the need for research into chronic communicable and non-communicable diseases in Africa and highlights the dilemma of appropriate use of resources in serving the world's medical needs.
Introduction
End stage renal failure (ESRF), because 
Results
Haemodialysis facilities at MMC are limited and are usually reserved for patients suffering from acute reversible renal failure such as that following obstetric accidents. Two of the nine patients (nos. 7 and 9) received some haemodialysis while awaiting transfer to London. All arrived in London in advanced uraemia, two patients exhibiting among the highest serum creatinines recorded at STH in recent years -4,302pmol/l (no. 5) and 1,980pmol/1 (no. 6).
Emergency haemodialysis was required for all except no. 1 and no. 8. Access was achieved by leg shunts or by double lumen or pairs of venous catheters inserted into the internal jugular, subclavian and occasionally femoral veins. The total number of haemodialyses (Table II) was dictated by the medical state of the recipient and the preparation of the donor. Immediate graft reduction occurred in all ten transplants.
Postoperative complications (Table II) were dominated on the surgical side by a high incidence of urinary leaks (60%) due to breakdown of the ureteric anastomosis to the bladder, usually the consequence of ischaemic necrosis. Bacteraemia and scpticaemia accompanied some of these leaks. Definitive surgical management in four cases was atchieved by pelvi-ureterostomy using the recipients ipsilateral ureter and splinting the anastomosis with (l T tube into the bladder.
Initial immunosuppression was by azathioprine and steroids for the first graft of patient no. 1 and for patient no. 2, thereafter cyclosporin and low dose steroids were used. Cyclosporin (4mg/kg) was given by slow (6 hours) i.v. infusion on each of the first 3 days and then replaced by oral cyclosporin 13mg/kg/day reducing by 2mg/kg/day weekly.
Prednisolone 20mg/day was given in conjunction with the cyclosporin. After 6 to 8 weeks azathioprine was introduced and its dose progressively increased to 100 and 150mg/day while cyclosporin was gradually withdrawn. Several patients had rejection episodes during the switch of therapy or immediately after it and oral steroid dose was often increased to cover the switch. All patients had rejection episodes at some time and these were managed in in-patients by i.v. bolus injections of methylprednisolone 0.5 g on 2 to 3 consecutive days and in out-patients by oral high dose prednisolone, increased to 100mg/day for 3 days, thereafter tapered by 25mg/day every third day.
Malaria occurred in the first three cases during the first few weeks after transplant and one of these was associated with a rejection episode. Malaria in Tanzania is often chloroquine resistant4 and all donors and patients have since been given a course of quinine and pyrimethamine (Fansidar) as a precautionary measure, even if blood films were negative.
Hypertension was a medical complication, to all the cases. Severe hypertension with left ventricular failure developed acutely during the first 48 hours in three patients, each of whom required either venesection or a nitroprusside infusion to prevent pulmonary oedema and death.
Heart failure occurred in the presence of dramatic polyuria (often exceeding 10 litres per 24 hours) and without overall weight gain and appeared to be due to a severe increment in peripheral vascular resistance. All patients required powerful long-term oral hypotensive agents. Minoxidil was found particularly useful in conjunction with beta-blockade and usually diuretics and was even preferred by one female patient despite the side effect of hirsutism necessitating regular facial shaving.
The steroids used for immunosuppression induced non-ketotic diabetes in four of the patients. All four required insulin during the early months but the dose required was eventually diminished and in one patient management by diet alone proved satisfactory. All patients returned to Tanzania with functioning grafts having spent between 3 and 6 months in London for early post-transplant follow-up and the switch of immunosuppressive drugs. However, several patients had hearts which had been severely damaged by long-standing hypertension and two of these (no. 3 and no. 7) died quite suddenly 3 weeks after reaching their homes. Seven out of the ten grafts were functioning in April 1987, but the graft of patient no. 4 which suffered repeated rejection episodes in earlier months, two years after transplantation showed declining renal function.
The first graft in patient no. I was lost after 2 years and it seems likely that poor control of hypertension was the major factor. The transplant from a second brother continues with stable function and she is reconciled to the use of minoxidil to control her hypertension which she monitors with her own sphygmomanometer.
Rehabilitation of the patients has been of variable quality. One has been able to continue a full academic life as a university professor and another, a trained pilot and the only patient to discontinue hypotensive drugs so far, has been restored to flying duties. Two of the female patients have young children to care for and one is a young girl whose earlier illnesses interrupted her education and would have cut her life short on the threshold of adulthood. One of the survivors (no. 6) married after return to Tanzania but subsequently lost his job and became confused and psychotic, requiring psychiatric care.
Discussion
A strategy of LRD transplantation was adopted as the most cost effective. However, the average cost of each patient's treatment, including accommodation and living allowances in London and drugs for one year, amounted to the equivalent of almost 2 million Tanzanian shillings (roughly equivalent to £20,000 sterling at present rates of exchange, although this has altered during the years covered by this programme). This must be placed in the context of a total government health expenditure of less than one hundred Tanzanian shillings per subject per year. Despite this stark comparison it is the firm view of the clinicians at MMC that patients should not be totally debarred from transplantation. The productive lives to which several of these patients have been restored underlines the dilemma confronting developing countries when such expensive high technology medicine has been shown to be so effective. The true cost of transplantation can be judged properly only when compared to the cost of training a pilot or to the value of an internationally active university professor. Cost in London was primarily dependent on the length of hospitalization in STH and in the period of preparatory dialysis and it is therefore pertinent to consider all factors which delay transplantation. Only three of the transplants were planned electively, both grafts in patient no. 1 and that of patient no. 8. All other patients were desperately ill on arrival in London, their transfer sometimes delayed by administrative hold-ups and this necessitated urgent haemodialysis and made it impossible to carry out the LRD The complications encountered illustrate particular surgical and medical problems which we have now come to anticipate and which make us regard many of these patients as 'high risk' candidates for dialysis and transplantation. The high incidence of urinary leaks has not been matched by a similar experience in our UK or other foreign patients.
Chloroquine-resistant malaria must be considered ubiquitous4 and it is a particular hazard in immunosuppressed patients. It After return to Tanzania immunosuppression was continued with azathioprine and low dose steroids. Azathioprine was chosen for long-term immunosuppression because of the high cost of cyclosporin, even in low doses currently employed. The risks of switching these drugs after three months is well documented.7 Successful switching is possibly even more difficult to achieve during the first 3 months, but our objective was probably helped by using related donors and no grafts were lost during this process despite severe rejection episodes which were encountered.
The small programme reported in this paper establishes that successful renal transplantation can be offered to subjects of a country which does not yet envisage the inception of an autonomous programme of dialysis and transplantation for ESRF. Collaboration between clinicians at MMC and STH now obviates any necessity for patients to return to London for routine follow-up. It is also improving the efficiency of transfer arrangements to diminish risks to the patient and overall costs. Finally, by highlighting the ultimate costs of glomerulonephritis and hypertension we draw attention to widespread and chronic medical problems in the population which call for research, prevention and treatment.
